Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-010137

Dake Benjamin T sold 3,325 shares at $31.97 ($106,317)

  • Dake Benjamin T acquired 3,325 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Exercise or conversion : show line 1 in the form 10b5-1 +3,325 $10.61 $35,278 4,616 D
2024-04-01 Sale : show line 2 in the form 10b5-1 −3,325 $31.97 $106,317 1,291 D
Open-market sales · 3,325 sh · avg $31.97 · $106,317

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −3,325 25,675 D
Loading xslF345X05/form4-04032024_060406.xml…